MEDA Pharma GmbH & Co. KG
MEDA Pharma GmbH & Co. KG, a prominent player in the pharmaceutical industry, is headquartered in Germany and operates extensively across Europe and beyond. Founded in 1993, the company has established itself as a leader in the development and distribution of prescription and over-the-counter medications, particularly in the fields of dermatology, respiratory health, and pain management. With a commitment to innovation, MEDA Pharma offers a diverse portfolio of unique products that cater to the specific needs of patients and healthcare professionals. The company’s focus on high-quality formulations and patient-centric solutions has earned it a strong market position and recognition for excellence in the pharmaceutical sector. Through strategic partnerships and a robust distribution network, MEDA Pharma continues to expand its reach and impact in the healthcare landscape.
DitchCarbon Score
How does MEDA Pharma GmbH & Co. KG's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
MEDA Pharma GmbH & Co. KG's score of 29 is lower than 100% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
MEDA Pharma GmbH & Co. KG's reported carbon emissions
MEDA Pharma GmbH & Co. KG, headquartered in Germany, currently does not have publicly available carbon emissions data or specific reduction targets. Without concrete figures or commitments, it is challenging to assess their climate impact or initiatives. However, the pharmaceutical industry is increasingly focusing on sustainability and reducing carbon footprints. Companies are encouraged to adopt science-based targets and engage in climate pledges to mitigate their environmental impact. As MEDA Pharma continues to operate within this evolving landscape, it may consider establishing measurable climate commitments in line with industry standards.
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
MEDA Pharma GmbH & Co. KG is not participating in any of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
